These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 19273730)

  • 1. Duration of symptoms is the key modulator of the choice of reperfusion for ST-elevation myocardial infarction.
    Armstrong PW; Westerhout CM; Welsh RC
    Circulation; 2009 Mar; 119(9):1293-303. PubMed ID: 19273730
    [No Abstract]   [Full Text] [Related]  

  • 2. Duration of symptoms is not always the key modulator of the choice of reperfusion for ST-elevation myocardial infarction.
    Bogaty P
    Circulation; 2009 Mar; 119(9):1304-10. PubMed ID: 19273731
    [No Abstract]   [Full Text] [Related]  

  • 3. Transient exacerbation of ST-segment elevation upon reperfusion in acute myocardial infarction.
    Steg PG; Dellborg M; Simoons M
    J Electrocardiol; 1993; 26 Suppl():156. PubMed ID: 8189118
    [No Abstract]   [Full Text] [Related]  

  • 4. Lowering mortality in ST-elevation myocardial infarction and non-ST-elevation myocardial infarction: key prehospital and emergency room treatment strategies.
    Goldstein P; Lapostolle F; Steg G; Danchin N; Assez N; Montalescot G; Charpentier S; Wiel E; Juliard JM
    Eur J Emerg Med; 2009 Oct; 16(5):244-55. PubMed ID: 19318957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of the electrocardiogram in optimizing reperfusion for ST-elevation myocardial infarction: a new role for an old tool?
    Kasapis C; Nallamothu BK
    Eur Heart J; 2007 Dec; 28(24):2957-9. PubMed ID: 18006542
    [No Abstract]   [Full Text] [Related]  

  • 6. [Intensive anti-platelet treatment: a new viewpoint in reperfusion strategy for ST segment elevation myocardial infarction].
    Huo Y; Chen M
    Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(16):1091-2. PubMed ID: 16796831
    [No Abstract]   [Full Text] [Related]  

  • 7. [Electrocardiography in the diagnostics of acute myocardial infarction with ST elevation].
    Smalcelj A
    Acta Med Croatica; 2009 Feb; 63(1):9-14. PubMed ID: 19681455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of angiographic and electrocardiographic parameters of reperfusion to prediction of mortality and morbidity after acute ST-elevation myocardial infarction: Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction trial.
    Brener SJ; Westerhout CM; Fu Y; Todaro TG; Moliterno DJ; Wagner GS; Granger CB; Armstrong PW;
    Am Heart J; 2009 Nov; 158(5):755-60. PubMed ID: 19853693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ACC/AHA guideline update for the management of ST-segment elevation myocardial infarction.
    Campbell-Scherer DL; Green LA
    Am Fam Physician; 2009 Jun; 79(12):1080-6. PubMed ID: 19530638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical benefit of early reperfusion therapy in patients with ST-elevation myocardial infarction usually excluded from randomized clinical trials (results from the Maximal Individual Therapy in Acute Myocardial Infarction Plus [MITRA Plus] registry).
    Koeth O; Zahn R; Gitt AK; Bauer T; Juenger C; Senges J; Zeymer U;
    Am J Cardiol; 2009 Oct; 104(8):1074-7. PubMed ID: 19801027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Myocardial infarction aborted by rapid percutaneous coronary intervention].
    van Etten J; Verheugt FW
    Ned Tijdschr Geneeskd; 2009; 153():A467. PubMed ID: 19785883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reperfusion therapy for acute ST-elevation and non ST-elevation myocardial infarction: what can be achieved in daily clinical practice in unselected patients at an interventional center?
    Zahn R; Schweppe F; Zeymer U; Schiele R; Gitt AK; Mark B; Frilling B; Seidl K; Winkler R; Heer T; Schneider S; Senges J
    Acute Card Care; 2009; 11(2):92-8. PubMed ID: 19391052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The challenge of reducing time to reperfusion in patients with acute ST elevation myocardial infarction.
    van 't Hof AW
    Eur Heart J; 2008 Aug; 29(15):1793-4. PubMed ID: 18617476
    [No Abstract]   [Full Text] [Related]  

  • 14. Percutaneous coronary intervention-related time delay, patient's risk profile, and survival benefits of primary angioplasty vs lytic therapy in ST-segment elevation myocardial infarction.
    De Luca G; Cassetti E; Marino P
    Am J Emerg Med; 2009 Jul; 27(6):712-9. PubMed ID: 19751630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic impact of Q waves on presentation and ST resolution in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Kumar S; Hsieh C; Sivagangabalan G; Chan H; Ryding AD; Narayan A; Ong AT; Sadick N; Kovoor P
    Am J Cardiol; 2009 Sep; 104(6):780-5. PubMed ID: 19733711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation between myocardial infarct size and ventricular tachyarrhythmia among patients with preserved left ventricular ejection fraction following fibrinolytic therapy for ST-segment elevation myocardial infarction.
    Pride YB; Appelbaum E; Lord EE; Sloan S; Cannon CP; Sabatine MS; Gibson CM;
    Am J Cardiol; 2009 Aug; 104(4):475-9. PubMed ID: 19660597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reperfusion therapy for ST-segment elevation myocardial infarction: trials, registries, and guidelines.
    Verheugt FW
    Circulation; 2009 Jun; 119(24):3047-9. PubMed ID: 19506103
    [No Abstract]   [Full Text] [Related]  

  • 18. [Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation].
    Van de Werf F; Bax J; Betriu A; Blomstrom-Lundqvist C; Crea F; Falk V; Filippatos G; Fox K; Huber K; Kastrati A; Rosengren A; Steg PG; Tubaro M; Verheugt F; Weidinger F; Weis M; ; ; Vahanian A; Camm J; De Caterina R; Dean V; Dickstein K; Filippatos G; Funck-Brentano C; Hellemans I; Kristensen SD; McGregor K; Sechtem U; Silber S; Tendera M; Widimsky P; Zamorano JL; Silber S; Aguirre FV; Al-Attar N; Alegria E; Andreotti F; Benzer W; Breithardt O; Danchin N; Di Mario C; Dudek D; Gulba D; Halvorsen S; Kaufmann P; Kornowski R; Lip GY; Rutten F; Societá Europea di Cardiologia
    G Ital Cardiol (Rome); 2009 Jul; 10(7):450-89. PubMed ID: 19761103
    [No Abstract]   [Full Text] [Related]  

  • 19. Cost effectiveness of enoxaparin in acute ST-segment elevation myocardial infarction: the ExTRACT-TIMI 25 (Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction 25) study.
    Marcoff L; Zhang Z; Zhang W; Ewen E; Jurkovitz C; Leguet P; Kolm P; Weintraub WS
    J Am Coll Cardiol; 2009 Sep; 54(14):1271-9. PubMed ID: 19778669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of renal function on the effects of early revascularization in non-ST-elevation myocardial infarction: data from the Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART).
    Szummer K; Lundman P; Jacobson SH; Schön S; Lindbäck J; Stenestrand U; Wallentin L; Jernberg T;
    Circulation; 2009 Sep; 120(10):851-8. PubMed ID: 19704097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.